Palatin Technologies Inc. (PTN)

Trade PTN now with
8/19/2022 7:32:30 AM Palatin Intents To Effect 1-for-25 Reverse Stock Split On August 30
8/16/2022 7:31:33 AM Palatin Reports Positive Interim Analysis In Phase 3 Study Of PL9643 In Patients With Dry Eye Disease
7/26/2022 7:32:14 AM Palatin Technologies Q4 Net Product Revenue Up 225% Over Prior Quarter
5/17/2022 7:32:38 AM Palatin Technologies Q3 Net Loss $7.6 Mln Or $0.03/shr Vs Loss Of $5.7 Mln Or $0.02/shr Prior Year
2/15/2022 7:32:10 AM Palatin Q2 Net Loss $8.7 Mln Or $0.04/Shr Vs Oss Of $10.0 Mln Or $0.04/Shr Last Year
1/21/2022 7:32:14 AM Palatin Announces Presentation Of Positive Effects Of PL8177 On Treating Ulcerative Colitis In Animal Disease Model
12/28/2021 7:31:44 AM Palatin Begins Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial In Patients With Dry Eye Disease